A multi-national research team led by Duke Medicine scientists has identified a subclass of antibodies associated with an effective immune response to an HIV vaccine.The finding, reported in the journal Science Translational Medicine, helps explain why a combination of two vaccines was able to show some effect, when one vaccine alone did not. The study also provides key insights that could aid development of new vaccines."More is not always better with an antibody response," said senior author Georgia D. Tomaras, Ph.D.
No comments:
Post a Comment